Jann Elizabeth Skinner
Independent Non-Executive DirectorMs. Jann Elizabeth Skinner, BCom (UNSW) FCA FAICD, M.A, is Chief Marketing & Communications Officer of International of QBE European Operations Plc from January 2026. Ms. Skinner joined the QBE European Operations Plc in January 2026. Ms. Skinner serves as Non-Executive Director at Telix Pharmaceuticals Limited and served as its Independent Non-Executive Director since June 19, 2018. She has been a Director of Gordian Runoff Limited, TGI Australia Limited and Church Bay Limited since June 21, 2012. Ms. Skinner has extensive experience in audit and accounting and in the insurance industry. She was Director of Enstar Australia Group. She was also a Non-Executive Director on QBE’s Australian regulated boards. She had a long career with PricewaterhouseCoopers (PwC) from 1975 to 2004, where she was an Audit Partner. She had been an Independent Non-Executive Director at QBE Insurance Group Limited since October 1, 2014 until May 10, 2024. She serves as a Director at the Create Foundation Limited. She served as Independent Non-Executive Director at HSBC Bank Australia Limited, a manager of Lion Series 2022-1 Trust. since April 12, 2017 until April 12, 2023. Ms. Skinner serves as a Non-Executive Director of QBE's Australian APRA regulated insurance companies (QBE Australia). Ms. Skinner was Independent Director of Tasmanian Public Finance Corporation since October 2008. She served as a Director of QBE Insurance (International) Ltd. (NZ Branch) until February 20, 2015. She served as a Director of QBE Insurance (International) Limited and QBE Lenders' Mortgage Insurance Limited until February 20, 2015. She served as a Director of QBE Insurance (Australia) Limited until February 20, 2015. She is a Fellow of both Chartered Accountants Australia & New Zealand and the Australian Institute of Company Directors.
Positions
- Company NameTelix Pharmaceuticals LimitedStock CodeTLXPositionIndependent Non-Executive DirectorColleagues
- CPChristian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director
- DNDavid N. GillIndependent Non-Executive Chair of the Board
- DSDarren SmithGroup Chief Financial Officer
- DPDarren PattiGroup Chief Operating Officer
- DNDavid N. CadeGroup Chief Medical Officer
- PSPaul SchafferSVP of Research & Development
- MAMark Alexander NelsonIndependent Non-Executive Director
- MEMarie E. McDonaldIndependent Non-Executive Director
